Table 1.

Occurrence and resolution of LT cytopenias

AnemiaThrombocytopeniaLymphocytopeniaNeutropenia
All patients (N = 115), n (%)     
 Cytopenias resolved to grade ≤2 by 90 days 49 (43) 43 (37) 44 (38) 43 (37) 
 LT cytopenias 3 (3) 9 (8) 8 (7) 9 (8) 
Responders (n = 60) 
 Cytopenias resolved to grade ≤2 by 90 days 45 (75) 39 (65) 40 (67) 38 (63) 
 LT cytopenias 2 (3) 8 (13) 7 (12) 9 (15) 
Probability of grade 3 to 4 cytopenias not resolved to grade ≤2, % (95% CI)     
 Month 3 100 100 83 (27.3-97.5) 100 
 Month 6 50 (15.2-77.5) 42 (5.6-76.7) 44 (13.6-71.9) 
 Month 9 25 (3.7-55.8) 42 (5.6-76.7) 22 (3.4-51.3) 
 Month 12 NE 21 (0.9-59.5) NE 
AnemiaThrombocytopeniaLymphocytopeniaNeutropenia
All patients (N = 115), n (%)     
 Cytopenias resolved to grade ≤2 by 90 days 49 (43) 43 (37) 44 (38) 43 (37) 
 LT cytopenias 3 (3) 9 (8) 8 (7) 9 (8) 
Responders (n = 60) 
 Cytopenias resolved to grade ≤2 by 90 days 45 (75) 39 (65) 40 (67) 38 (63) 
 LT cytopenias 2 (3) 8 (13) 7 (12) 9 (15) 
Probability of grade 3 to 4 cytopenias not resolved to grade ≤2, % (95% CI)     
 Month 3 100 100 83 (27.3-97.5) 100 
 Month 6 50 (15.2-77.5) 42 (5.6-76.7) 44 (13.6-71.9) 
 Month 9 25 (3.7-55.8) 42 (5.6-76.7) 22 (3.4-51.3) 
 Month 12 NE 21 (0.9-59.5) NE 

LT cytopenias were defined as grade ≥3 occurring at or persisting beyond 90 days after infusion.

NE, not estimable.

or Create an Account

Close Modal
Close Modal